Edition:
India

Flex Pharma Inc (FLKS.OQ)

FLKS.OQ on NASDAQ Stock Exchange Global Market

0.88USD
20 Jul 2018
Change (% chg)

-- (--)
Prev Close
$0.88
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
52,864
52-wk High
$8.95
52-wk Low
$0.80

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -0.29 December 23 Jul 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 2 2
(2) OUTPERFORM 1 2 2 2
(3) HOLD 2 2 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.67 2.50 1.80 1.80

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 3 0.31 0.37 0.20 --
Quarter Ending Dec-18 3 0.37 0.43 0.30 --
Year Ending Dec-18 3 1.15 1.28 0.90 6.17
Year Ending Dec-19 3 11.31 26.73 1.61 28.62
Earnings (per share)
Quarter Ending Sep-18 3 -0.29 -0.17 -0.52 --
Quarter Ending Dec-18 3 -0.29 -0.13 -0.56 --
Year Ending Dec-18 3 -1.49 -1.22 -2.03 -2.50
Year Ending Dec-19 3 -0.86 -0.31 -1.73 -2.46

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 0.28 0.18 0.10 35.38
Quarter Ending Dec-17 0.45 0.28 0.17 37.29
Quarter Ending Sep-17 0.48 0.41 0.07 14.73
Quarter Ending Jun-17 0.51 0.34 0.18 34.76
Quarter Ending Mar-17 0.35 0.24 0.11 30.57

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 0.31 0.31 0.30 0.27 --
Quarter Ending Dec-18 0.37 0.37 0.32 0.30 --
Year Ending Dec-18 1.15 1.15 1.07 1.01 6.17
Year Ending Dec-19 11.31 11.31 8.70 7.10 28.62

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings